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Abstract
Background: Each year, over 300 million people undergo surgical procedures
worldwide. Despite efforts to improve outcomes, postoperative morbidity and
mortality are common. Many patients experience complications as a result of
either medical error or failure to adhere to established clinical practice
guidelines. This protocol describes a clinical trial comparing a
telemedicine-based decision support system, the Anesthesiology Control
Tower (ACT), with enhanced standard intraoperative care.
Methods: This study is a pragmatic, comparative effectiveness trial that will
randomize approximately 12,000 adult surgical patients on an operating room
(OR) level to a control or to an intervention group. All OR clinicians will have
access to decision support software within the OR as a part of enhanced
standard intraoperative care. The ACT will monitor patients in both groups and
will provide additional support to the clinicians assigned to intervention ORs.
Primary outcomes include blood glucose management and temperature
management. Secondary outcomes will include surrogate, clinical, and
economic outcomes, such as incidence of intraoperative hypotension,
postoperative respiratory compromise, acute kidney injury, delirium, and
volatile anesthetic utilization.
Ethics and dissemination: The ACTFAST-3 study has been approved by the
Human Resource Protection Office (HRPO) at Washington University in St.
Louis and is registered at clinicaltrials.gov (NCT02830126). Recruitment for this
protocol began in April 2017 and will end in December 2018. Dissemination of
the findings of this study will occur via presentations at academic conferences,
journal publications, and educational materials.
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Introduction
Each year, over 300 million surgical procedures are performed
worldwide1. Unfortunately, many patients will experience significant morbidity or mortality in the postoperative period2.
Research conducted at our institution and others has demonstrated an early postoperative mortality rate ranging from
1–5% and 90-day to 1-year mortality rates between 5–10%2–13.
Additionally, 10–40% of patients will experience some type
of postoperative surgical complication, including surgical site
infection, respiratory complications, myocardial infarction,
stroke and acute kidney injury, resulting in a three- to seven-fold
increase in postoperative mortality3,4,11,12.
Despite the overall decline in surgical morbidity and mortality over time, the risk of perioperative adverse events remains
substantial2. Some of this risk may be a manifestation of either
underlying patient pathology or the complexity of the surgical procedure itself9,12,14,15. However, evidence also suggests
that medical errors contribute considerably to negative patient
outcomes16,17. Although some errors may be considered active,
such as the administration of an incorrect medication, the failure to follow established clinical practice guidelines and recommendations likely has a more significant overall detrimental
effect on patient outcomes. Prior studies have documented that
deviation from evidence-based standards of care is common,
and that this deviation results in poorer patient outcomes18–22.
Interventions to improve patient safety and outcomes remain
a major focus in anesthesiology. The complexity of anesthetic
practice can lead to frequent cognitive errors in the perioperative arena23,24, suggesting that the development of a real-time, tailored feedback system to support intraoperative decision-making
may be valuable. The development of automated feedback and
alerting systems has been demonstrated to improve adherence
to a number of treatment guidelines25–42. However, the impact of
decision support systems appears to decay over time43–46, and
improvements in process variables may not translate into improved
patient outcomes47.
In the intensive care unit (ICU), the use of remote monitoring to augment care, commonly referred to as “telemedicine,” decreases ICU mortality and the length of ICU stay, and
improves adherence to clinical practice guidelines48–52. While
this type of clinical decision support has seen robust adoption
in the critical care setting, its utilization in the intraoperative
care of surgical patients is limited50. In light of the benefits that
have been demonstrated from using telemedicine in the ICU
setting, we believe that the implementation of such a system
in the operating room has the potential to elevate the general
safety and quality of perioperative care.
We have designed a multifaceted approach for the development and institution of an Anesthesiology Control Tower
(ACT) to provide real-time intraoperative telemedicine decision
support. In the first component of our approach, we outlined
a strategy of iterative usability testing and platform modification that allowed us to develop a high-fidelity, user-centered
system53. We intend to continue separate usability analyzes over

the course of the pilot trial in order to evaluate the key usability
elements of effectiveness, efficiency, and satisfaction54 in a more
real-world setting. Because the impact of a clinical intervention is dependent on the success of the process through which
it is implemented55, we will also evaluate implementation outcomes that are relevant to the use of the ACT in the perioperative setting56,57. In the second component of our approach, we
will employ large-scale data analytics, integrating perioperative
information in order to create forecasting algorithms for negative patient trajectories58. In the current manuscript, we describe
the third element of our investigation: a pilot randomized controlled trial that aims to demonstrate the superiority of the ACT
in improving adherence to best care practices when compared
to enhanced usual care.

Methods and analysis
Overview of research design
The ACTFAST-3 study is a pragmatic comparative effectiveness trial that is taking place at an academic university-affiliated
and adult tertiary care hospital in the United States that performs over 19,000 surgeries a year. We plan to enroll approximately 12,000 patients over the study period, with approximately
6,000 patients in the control arm and 6,000 patients in the intervention arm (Figure 1). Patients will be included with a waiver
of informed consent, as approved by the Human Research
Protection Office (protocol number 201603038), as the risk
associated with the ACT has been deemed to be minimal.
Randomization will occur at the level of individual operating
rooms on a daily basis.
The ACT will monitor all patients in both the control and intervention operating rooms using information gathered from the
electronic medical record (EMR) and from a customized version of a perioperative monitoring and alerting program called
AlertWatch® (Ann Arbor, MI). AlertWatch is an FDA-cleared
(KI3O4OI) system that displays integrated patient information and alerts clinicians to physiologic derangements. It was
recently demonstrated that use of the AlertWatch software was
associated with improvements in several process measures,
although this did not translate into an effect on clinical outcomes47. For the purposes of our intervention, the commercially
available AlertWatch platform was heavily modified through
usability testing53 to create a customized AlertWatch “Control
Tower” mode that is only available within the ACT (Figure 2
and Figure 3). The standard platform will remain available to
all OR clinicians during this study. The ACT will provide clinicians in the intervention ORs with real-time feedback based on
the available electronic resources, including AlertWatch Control Tower. Anesthesia providers in rooms assigned to the control
group will also be monitored but will not receive decision
support. Notably, the standard medical staffing models for
providing an anesthetic will not be affected with this intervention, as the ACT is designed to augment decision-making,
rather than replace critical team members.
The primary outcome measures in the ACTFAST-3 pilot
study are compliance with best care practices for intraoperative temperature management and intraoperative blood glucose
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Figure 1. Flow diagram of study population.

management (Table 1). We will also explore additional intraoperative process measures in addition to surrogate outcomes
(Table 2). The incidence of intraoperative hypotension and the
incidence of postoperative renal dysfunction, atrial fibrillation,
respiratory failure and delirium will be assessed via review of
the EMR. Other postoperative complications, including intraoperative awareness, surgical site infection, readmission, and
death will be assessed via analysis of the existing Center for
Clinical Excellence Registry, American College of Surgeons’
National Surgical Quality Improvement Program (NSQIP) database, Society of Thoracic Surgery (STS) database, and Systematic Assessment and Targeted Improvement of Services
Following Yearlong Surgical Outcomes Surveys (SATISFYSOS) database59. Outcomes related to the usability of the ACT
intervention, including efficiency and efficacy of the software
platform, will be obtained from AlertWatch data logs. These
logs will also be used to obtain data related to the feasibility of
implementing the pilot ACT. User satisfaction will be assessed
through surveys administered to members of the anesthesia
department.

Study population, randomization, and blinding
The trial will include all adult patients undergoing surgery at
two campuses of an academic university-associated hospital,

Barnes-Jewish Hospital (South Campus and Parkview Tower)
(St. Louis, MI, USA), between 7:00 AM and 4:00 PM Monday through Friday (Figure 1). This includes a total of 48
operating room locations. The ACT will function on days when
at least two anesthesia providers are available, one of whom must
be an attending anesthesiologist. Patients undergoing surgical
procedures with greater than 50% of the case length occurring
outside of the ACT hours will be excluded from analysis. All
patients younger than 18 will also be excluded from the study.
Patients who undergo multiple surgeries in a single hospitalization or who have a second surgical procedure within 30 days of
their initial surgery will be analyzed according to their initial
randomization assignment. Patients returning for a second surgery more than 30 days after their initial surgical encounter will
be considered as separate patients in the analysis. We will also
obtain data from a group of historical control patients for
the 6 months prior to the initiation of the ACTFAST-3
study, as part of an analysis related to potential sources of bias and
contamination.
A randomization algorithm integrated into the AlertWatch system will direct patient group allocation on a daily basis. Due to
the nature of the intervention in this study, clinicians working in the ACT and those randomized to receive support
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Figure 2. Interface of the AlertWatch® Control Tower system. (A) AlertWatch® Control Tower Census View. This view shows summary
information for operating rooms with ongoing procedures. Physiological alerts (e.g., low blood pressure) are shown as black or red squares,
depending on the severity of the derangement, with red indicating a more severe abnormality. Checkmarks appear inside an operating room
when an alert is triggered that has been classified as actionable and requires a resonse on the part of the clinicians in the Control Tower (see
Figure 3). Control rooms are indicated with a “Do Not Contact” symbol. (B) AlertWatch® Control Tower Patient Display View. This deidentified
intraoperative patient display demonstrates organ-specific information individualized to each patient. Colors outlining organs indicate normal
(green), marginal (yellow) or abnormal function (red). Orange would indicate an organ system at risk due to pre-existing conditions. The left
side of the display shows patient characteristics and the case information. Lab values, if available, are listed beneath the kidneys. Alerts
generated by the AlertWatch® system are listed on the right-hand side of the display. Specific alerts, determined by the study team to be
clinically significant and actionable, trigger a checkmark to appear at the bottom left of the screen. This informs the Anesthesiology Control
Tower (ACT) clinician that an alert is present that must be addressed. Clicking on this checkmark allows clinicians in the ACT to review and
address these alerts (Figure 3).
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Figure 3. AlertWatch® Control Tower Case Review dialogue. Clinicians in the Anesthesiology Control Tower (ACT) use the Case Review
window to address actionable Control Tower alerts, indicated by checkmarks on the Census View and the Patient Display. Within this Case
Review window, clinicians document their assessment of the significant of each alert, what action they would recommend, and, in the case of
intervention operating rooms (ORs), the reaction of the clinician in the OR to the ACT support.

Table 1. Primary outcome measures and definitions.
Measure

Outcome

Intraoperative temperature
management

Proportion of patients with
final recorded intraoperative
temperature greater than 36°C

Intraoperative blood
glucose control

Proportion of cases with blood
glucose ≥180 mg/dl upon arrival
to the post-anesthesia recovery
area

cannot be blinded to the intervention. Researchers responsible for extracting data during the course of the study will be
blinded to group allocation at the time of extraction.

Primary intervention: ACT monitoring and decision support
A multidisciplinary team of clinicians in the ACT will
remotely monitor all active operating rooms at the campus
of interest. ACT clinicians will include attending anesthesiologists, anesthesiology fellows, anesthesiology residents, and
certified and student registered nurse anesthetists. Information

will be obtained in near real-time from multiple complementary sources, including the AlertWatch Control Tower software
(Figure 2) and the EMR. The clinicians in the ACT will use this
information to communicate with OR clinicians to help maintain
compliance with intraoperative best care practices and to assist
with the detection and management of physiological derangements32,60–63. These clinicians will evaluate all alerts generated
by the AlertWatch Control Tower notification system (Figure 3),
including alerts from both the intervention and the control operating rooms. For ORs allocated to the intervention arm, the
ACT will deliver decision support to the primary personnel caring for the patient via text message or telephone call. The clinician receiving the alert will determine the applicability of
the alert to the clinical situation and will choose whether to
carry out any recommendations sent by the ACT. In patients
with a persistent critical event, the ACT will offer real-time
assistance with crisis resource management.
Operating rooms assigned to the control group will undergo
the same monitoring and assessment by the ACT, but
clinicians in these ORs will not receive any contact from the
ACT. However, if clinicians staffing the ACT feel ethically
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Table 2. Secondary outcome measures and definitions.
Intraoperative process measures

Outcomes

    Intraoperative blood pressure
management

Mean duration of time spent with Mean Arterial Pressure <60 mmHg

    Temperature monitoring

Proportion of procedures lasting greater than 1 hour with documented
temperature

    Antibiotic dosing

Proportion of procedures with appropriate administration of repeat doses of
antibiotics

    Intraoperative blood glucose
management

Proportion of cases with at least one dose of insulin administered for blood
glucose greater than 180 mg/dl
Intraoperative measurement of blood glucose in patients with type 1
diabetes undergoing cases ≥1 hour in length and patients with type 2
diabetes undergoing cases ≥2 hours in length

    Train of four documentation

Proportion of cases with a train of four documented prior to extubation if a
nondepolarizing neuromuscular blocking agent was administered

    Ventilator management

Proportion of cases with median tidal volume less than 10 ml/kg ideal body
mass

    Volatile anesthetic utilization

Mean and standard deviation of fresh gas flow rates for cases with volatile
anesthetic use >80% of case duration

Postoperative surrogate measures Outcomes
    Postoperative acute renal failure

Incidence of individual outcomes

    Postoperative atrial fibrillation
    Postoperative respiratory failure
    Postoperative delirium
    Intraoperative awareness
    Surgical site infection
    30-day readmission
    30-day mortality

obliged to contact a room assigned to the control group due
to perceived potential for imminent and significant patient
harm, they will be able to do so. Although we anticipate that
this will be a rare occurrence, it will still be documented and
reported as part of our study outcomes.

Data collection and outcome measures
Data collection for this study will utilize multiple sources to
extract outcome measures64. All alert data generated by the AlertWatch Control Tower platform will be automatically logged
to a secure database, including all responses by the providers in
the ACT to individual alerts (Figure 3). Data from the perioperative period will be imported from Metavision® (iMDsoft,
Wakefield, Massachusetts, USA), the anesthesiology information management software system currently in use by the
Department of Anesthesiology. In addition to capturing comprehensive intraoperative clinical data, Metavision® also stores
preoperative information, such as patient characteristics, clinical
and surgical history, comorbidities, and data from the immediate post-operative period. Of note, during the anticipated
duration of this trial, our hospital system will be transitioning
to Epic Systems software (Verona, WI, USA) for both the hospital electronic health record and the anesthesiology information management software. Postoperative data for patient

outcomes will be obtained from the inpatient EMR record
system, and from clinical registries (SATISFY-SOS, NSQIP, STS).

Primary outcome measures
The primary outcome measures in the ACTFAST-3 study are
compliance with recommendations for intraoperative temperature management and intraoperative blood glucose management (Table 1). Data on primary outcomes measures will be
recorded to an SQL server.
Secondary outcome measures
Secondary intraoperative outcomes will include several process,
surrogate, clinical measures (Table 2). Intraoperative process
outcomes will include blood pressure management, compliance with recommendations for repeat dosing of antibiotics and
for temperature monitoring, management of hyperglycemia,
documentation of train of four monitoring following neuromuscular blockade, and adherence to strategies for intraoperative
low tidal volume ventilation. Additionally, the impact of the
ACT on volatile anesthetic usage will be assessed. We will also
evaluate surrogate and clinical outcomes, specifically, the incidence of postoperative acute renal failure, postoperative atrial
fibrillation, postoperative respiratory failure, postoperative delirium, intraoperative awareness, surgical site infection, 30-day
Page 7 of 15
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hospital readmission, and 30-day mortality. Data will be obtained
from review of electronic health records and cross-referencing of patients in the ACTFAST study with other surgical databases, as described above. We will also track the incidence of
provider-reported intraoperative adverse events via a review of
the departmental quality improvement database. Feasibility of
implementing the ACT will be determined in part by examining
the number of potentially staffed days versus the actual number
of staffed days. Usability outcomes will include metrics such as
the median number of alerts addressed by provider and across
time.

Data analysis
Comparisons between groups will be with parametric and nonparametric statistical tests, as appropriate. Fisher’s exact or χ2 test
will be used to evaluate primary outcome measures with regards
to the following proportions: (i) the proportion of patients with
a last-documented intraoperative temperature greater than 36
degrees Celsius; and (ii) the proportion of patients arriving to the
post-anesthesia care unit or ICU with a blood glucose greater than
180 mg/dl. Contingency statistical tests will be used to compare
occurrence of hypothermia and hyperglycemia between groups.
Secondary outcomes will be compared between groups using
χ2 or Fisher’s exact test for categorical outcomes, and two-sided
t tests with unequal variances for comparison of means. By convention, statistical significance will be based on a two-sided
p value <0.05. All statistical testing will performed using SAS®
version 9.4 (SAS Institute Inc., Cary, North Carolina, USA).
The small subset of rare patients in the control group whose
provider may be contacted by the ACT clinicians out of concern for a significant patient safety event will be included in
the control group in an intention-to-treat analysis. A sensitivity
analysis will also be performed with inclusion of these patients
in the intervention group. The frequency and rationale for
contacting these rooms will be reported as part of our trial results.
Once the ACT intervention is executed, we anticipate several
sources of contamination effect in the control group. There is
a high likelihood of a robust Hawthorne effect due to OR clinician awareness of the ACT monitoring65,66. Also, all clinicians
in the OR will eventually be included in the intervention group,
due to the unit of randomization, and will likely become aware
of the best management practices of interest in this trial. Therefore, even on days when they do not receive ACT support,
clinicians may change their behavior, leading to overlapping
improvements in both groups over the course of the study. Additionally, utilization of the AlertWatch software by clinicians in
the ORs may increase over time. Learning effects might manifest most strongly among clinicians who staff the ACT and are
therefore sensitized to the interventions and outcomes in this
study. In order to evaluate the extent of the contamination and
Hawthorne effects, we will collect baseline data for the group
of historical controls. For categorical variables, contamination will be analyzed using logistic regression with a three-level
categorical variable representing group assignment (historical cohort, control group, or intervention group); continuous
variables will be analyzed using ANCOVA or non-parametric
ANCOVA67. Additionally, we will track which operating

rooms utilize the AlertWatch system intraoperatively, and will
plan to perform a subgroup analysis to assess the effect of the
ACT in this subset of patients.
Within the AlertWatch system, all alerts that are generated are
automatically logged to a secure database, as are all responses
of the ACT clinicians to these alerts (Figure 3). We will
analyze these logs to determine how clinicians in the ACT monitor patients, address alerts, and interact with OR clinicians, and
how OR clinicians respond to the ACT support. This data will
allow us to explore aspects of the real-world usability of the
ACT intervention related to efficiency and effectiveness, and
will complement information gathered from qualitative usability
surveys administered to department members.

Sample size and power analysis
In this study, we plan to enroll a convenience sample of
12,000 patients over the course of the study period, based
on the staffing available for the ACT and the usual daily
surgical volume of approximately 125 cases. Power analysis
was based on the two primary outcomes defined for this study,
with the following assumptions:
i) Regarding the core-temperature outcome, we conservatively assumed that only 80% of Barnes-Jewish Hospital
patients have their core temperature recorded during surgery. Among patients with their temperature documented,
the target for this outcome was that the ACT intervention
will increase the proportion of patients whose final recorded
intraoperative temperature is above 36°C from 60% to
95%. For this calculation we assumed a standard deviation
of core temperature of 0.9 degrees Celsius for both groups,
based on an unpublished EMR audit.
ii) Regarding the primary outcome of glucose control, we
assumed that the prevalence of diabetes mellitus among
Barnes-Jewish Hospital surgical patients is about 20%,
based on our EMR data over the past 5 years. Based on
the same data, we also assumed that currently 60% of our
diabetic patients reach a blood glucose >180 mg/dl at any
point during surgery. Our goal was that the ACT intervention will reduce the proportion of patients arriving to the
Post Anesthesia Care Unit (PACU) with a blood glucose
value greater than 180 mg/dl from 60% to 40%.
A statistical power calculation based on the above assumptions
was performed for each of the two primary study outcomes to
determine whether the sample size (N=12,000) allocated for
this study is adequate. The effective sample size for the study
was defined as the largest sample needed to achieve any of the
two stated outcomes. We mainly powered all targeted outcomes
to detect a difference in proportions (adjusted for contamination between the two study groups) in a completely balanced
clustered-randomized design study (24 operating rooms in each
group) using two-sided Z-test statistics. We also assumed a minimum to 90% power, a significance level of 0.05, an intracluster
correlation coefficient (ICC) varying between 0.01 and 0.05 by a
small increment of 0.005, and a coefficient of variation of cluster
sizes of 0.50. Table 3 shows the required sample per operating
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room as well as the overall sample needed to achieve the
study targeted outcomes. The largest sample was required for
the proportion of patients whose last recorded intraoperative
temperature is equal to or greater than 36°C (N=11,472). This value
was sufficient for the other primary outcome.

Substudy in educational curriculum
While the primary goal of the ACTFAST-3 study is to evaluate the impact of the ACT on patient care and outcomes, the
structure and environment of the ACT has allowed for the creation of a novel curriculum in perioperative medicine. The
current educational paradigm for anesthesiology residents primarily focuses on the management of individual patients in the
perioperative setting. However, the substantial increase in requirements for surgical procedures, a projected shortage of anesthesiologists, and financial constraints in healthcare suggest that it
will eventually be infeasible for anesthesiologists to provide the
level of supervision that is currently standard in the United States
(e.g. one anesthesiologist for every one to four ORs)68. There is
currently little emphasis in anesthesiology education on process
management and multitasking and caring for multiple patients
in a complex care environment. With the support of the residency program director and departmental chair, we have revised
the residency curriculum at our institute to allow each anesthesia resident to spend 2 weeks in the ACT during their final
year of residency. We plan to implement an educational curriculum in perioperative telemedicine, focusing on the utilization of healthcare system resources to optimize intraoperative
management, improve quality, and provide oversight of multiple
patients undergoing complex surgical procedures.
Adverse events and safety monitoring
We do not anticipate the occurrence of significant adverse
events during this study. However, the primary investigator and
the study team will review any adverse events identified by the
departmental quality improvement program as potentially attributable to the ACT. The occurrence of any significant adverse
events will be reported to the HRPO, and the study team and
HRPO would decide together whether to halt the trial. No formal
data-monitoring committee will used. There will be no audit of
trial conduct during the investigation, although data recorded
via the AlertWatch system will be reviewed and analyzed to
determine appropriate group allocation and inclusion in the

final analysis. No interim data analysis is planned for this
pilot trial unless unanticipated safety issues are identified.
There are no provisions for post-trial care or compensation
to patients enrolled as part of this trial, as the intervention in
the ACTFAST-3 trial involves only the addition of real-time
decision-support tools and does not change existing anesthesia
care models.

Data management
The risk of breach of confidentiality will be minimized. The
data necessary for the completion of the trial will be protected by passwords and is contained in applications that are
compliant for protected healthcare information (PHI). AlertWatch
meets this same standard of protection. Individual clinical alerts
and the ACT evaluation of these alert will be documented using
an electronic data capture tool in the AlertWatch system. Outcomes data will be stored on one of two Washington University
Department of Anesthesiology servers (a SQL server or a Windows file server). Only trained employees of the Department of
Anesthesiology or Barnes Jewish Healthcare are granted access to
resources on this network. Access to the contents of this study will
be further restricted to approved personnel only, using server-level
permission access (for the SQL server), or Windows folder permission settings (for the file server). It is a strict policy that PHI
cannot be saved or reviewed outside of this protected environment. Whenever possible, extracts for this project will avoid
the use of this information. Data extracts can be reconnected
to PHI using a special, non-PHI primary key, which this group
has successfully used with previous studies.
Strengths and limitations
The ACTFAST pilot study has important strengths. It is a randomized clinical trial conducted in a high volume, real world
clinical setting and can be conducted efficiently, as many components of the proposed study are incorporated into existing
infrastructures and processes at Washington University. This
includes access to existing information technology resources and
to established and ongoing registries (SATISFY-SOS, NSQIP
and STS). The data required for analysis of the primary outcome measures are routinely recorded on every patient undergoing surgery at our institution, and the databases used for analysis
of secondary surrogate and clinical outcomes also all have high
levels of data fidelity.

Table 3. Sample size assumptions and calculations for primary outcomes.

Outcome†

Current
practice

Cluster per group(size)

Target level*

Intervention

Control

Intervention

Control

Intracluster
correlation
coefficient

Total
Sample
Required

Core temperature:
proportion
reaching 36°C

50%

24(239)

24
(239)

95%

90%

0.0375

11,472

Post- operative
Blood Glucose ≥
180 mg/dL

60%

24(59)

24
(59)

40%

50%

0.03

2,832

†See Table 1 for full explanation of outcomes.
*High contamination effects were set to reach 67% as 2 out of 3 physicians will participate in the ACT.
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Randomization of anesthesiology care teams can be easily implemented, and the process for providing feedback alerts
does not require any advanced preparation on the part of clinicians working in the OR. These clinicians will participate in
the ACTFAST trial in the course of their routine clinical work,
and the impact on overall workflow and workload will be minimized through the testing in our first phase of the study53. We
anticipate that it will be feasible to staff the ACT during the pilot
RCT. The feasibility is enhanced by participation of a highly
committed cadre of attending anesthesiologists and all of
the residents in the anesthesiology department, as well as an
experienced team of investigators that has established a track
record of collaboration and completion of major clinical trials.
The following limitations should be considered. The AlertWatch software is currently available on all computers in
the OR, and in-room provider utilization of AlertWatch may
increase over the course of the study. In response, we plan to
conduct a subgroup analysis with user log-in data to ascertain
the impact of in-room software utilization, defined as documentation of intraoperative provider log-in to the AlertWatch
system. Also, the ACTFAST study will be vulnerable both to
Hawthorne and contamination effects. While we do not think
that these effects can be eliminated, we have considered
how best to account for them in the analyses. An important
constraint and possible source of bias will be that it will not be
possible to ensure blinding of OR clinicians as any communication from the ACT will inform them that their operating room
is in the intervention group on that day69. However, clinicians
outside of the OR, and the researchers responsible for extracting
data, will be blinded to group assignment.
Another potential source of bias involves the existing surgical databases that will be used during analysis (i.e. STS, NSQIP,
SATISFY-SOS). These registries themselves may be biased
according to which patients choose to participate, with individual patients’ outcomes impacting their willingness or ability
to provide reliable information, and which patients are contactable. We have been attempting to mitigate this source of bias by
employing three modalities (e-mail, telephone and mail) to reach
patients postoperatively in one such study59. Overall, the registries have impressive response rates, and there does not appear
to be systematic bias in any of these registries based on baseline
patient characteristics. Therefore, we expect our data sources
to be robust, with minimal deficiencies.

Ethics and dissemination
This study was approved by the HRPO at Washington University (St. Louis, MI, USA, protocol number 201603038). This
protocol is written in compliance with the Standard Protocol
Items: Recommendations for Interventional Trials (SPIRIT)
checklist with consideration of the Consolidated Standards of
Reporting Trials (CONSORT) guidelines70,71.
If the results of the pilot ACTFAST-3 trial show benefit, the
pilot study will likely be replicated as a larger, multicenter study
for further validation that this intervention remains beneficial
and that it is feasible to institute at other centers. We also anticipate the expansion of the ACT into the surrounding healthcare

facilities within our hospital system. Larger trials could focus
on expanded clinical and patient-reported outcomes (e.g. death,
renal failure, delirium, duration of mechanical ventilation, intensive care length of stay, post-discharge disposition, postoperative
falls, return to work, disability-free survival). The ACT infrastructure could also be used to explore current controversies
in perioperative care by testing candidate experimental
interventions (e.g., fluid management strategies, blood transfusion triggers). We envision that national implementation
of the ACT concept would occur, which would be
comparable to the path that similar programs for intensive care
units have followed.
Any significant changes to the protocol or the analysis plan
during the trial will be communicated directly to the Washington University HRPO, as well as via update of the ACTFAST-3
registration at clinicaltrials.gov (ClinicalTrials.gov Identifier:
NCT02830126). We also plan to publish any modifications
made to this protocol during dissemination of the results of the
trial. Authorship for the final trial data will be determined in
accordance with International Committee of Medical Journal
Editors (ICMJE) guidelines.

Data sharing
Data from the ACTFAST-3 trial will be made available for analysis in compliance with the recommendations of the ICMJE72. For
this study, individual participant data that underlie the results of
the trial will be made available after appropriate deidentification, along with the study protocol and statistical analysis plan.
We plan to make this information accessible to researchers who
provide a methodologically appropriate proposal for the purpose
of achieving the aims of that proposal. Data will be available
beginning 9 months and ending 36 months following trial publication at a third-party website. Data requestors will need to sign
a data access agreement to gain access to trial data. Proposals
should be directed to avidanm@wustl.edu.

Conclusions
Despite aggressive efforts aimed to improve the quality of perioperative care, the risk of morbidity and mortality following a
major surgical procedure remains substantial. In this protocol,
we describe a pilot pragmatic, randomized, controlled trial in
intraoperative telemedicine that examines the ability of a novel
system of real-time feedback to improve adherence to perioperative best care practices. We hypothesize that the implementation
of the ACT will be feasible and that it will increase clinician
compliance with clinical practice standards. The development of
the ACT, as described in this protocol, will also lay the groundwork for a subsequent large randomized controlled trial examining the utility of the ACT in improving patient outcomes
following surgical procedures.
The findings from the trial will be disseminated in the form
of posters and oral presentations at scientific conferences, as
well as publications in peer-reviewed journals. Updates and
results of the study will be available at https://clinicaltrials.gov/
ct2/show/NCT02830126.
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implementation and utility of the anesthesiology control tower (ACT) in improving adherence to best care
practices when compared to enhanced usual care. The authors propose to randomize 12,000 patients
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The manuscript is eloquently written and the study protocol comprehensively described; our comments
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In this article the authors present a study protocol for a randomized control trial in the field of
intraoperative clinical decision support. The authors propose to randomize 12,000 patients to either
intraoperative clinical decision support or enhanced intraoperative clinical decision support by utilizing a
novel Anesthesia Control Tower (ACT) concept. Throughout the article the authors thoroughly present
their pragmatic study with adequate details and a thoughtful patient-centric approach. Their identification
of the complexity of the anesthetic practice and cognitive requirements is well founded, and their
reference to the ICU remote monitoring systems is established.
On page 3, paragraph 1, the authors state that “10-40% of patients will experience some sort of
postoperative surgical complication”. The citations mostly refer to elderly and/or high-risk surgical
patients. Perhaps the authors could consider adding a reference for a general surgical population.
On page 4, the authors state the ACT will function only on days with at least 2 anesthesia providers
available. Could this introduce bias into the study as on OR days with high volume, or complex cases
requiring lower staffing ratios, the availability of staff for the ACT would be less likely?
On page 7, paragraph 2, the authors state an anticipated transition in electronic health records. In our
experience, implementation of a new record keeping system can increase cognitive load, documentation
errors, and lags in data acquisition. Our concern would be a possible compromise of study data. Do the
authors have a contingency/transition plan available?
On page 8, the authors base the sample size calculation on core temperature measurements. The rest of
the manuscript is less specific as to the site of temperature measurement. Will only core temperatures be
utilized in this study?
On page 9, paragraph 2, the authors propose an innovative educational curriculum. Would the authors
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Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Yes
Competing Interests: No competing interests were disclosed.
We have read this submission. We believe that we have an appropriate level of expertise to
confirm that it is of an acceptable scientific standard.

The benefits of publishing with F1000Research:
Your article is published within days, with no editorial bias
You can publish traditional articles, null/negative results, case reports, data notes and more
The peer review process is transparent and collaborative
Your article is indexed in PubMed after passing peer review
Dedicated customer support at every stage
For pre-submission enquiries, contact research@f1000.com

Page 15 of 15

